Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability–High Colon Cancer

PURPOSE: Recent clinical trials have reported response rates < 50% among patients treated with programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors for microsatellite instability–high (MSI-H) colorectal cancer (CRC), and factors predicting treatment response have not been fully...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyung, Jaewon, Cho, Eun Jeong, Kim, Jihun, Kim, Jwa Hoon, Kim, Jeong Eun, Hong, Yong Sang, Kim, Tae Won, Sung, Chang Ohk, Kim, Sun Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582482/
https://www.ncbi.nlm.nih.gov/pubmed/35038827
http://dx.doi.org/10.4143/crt.2021.1133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582482/
https://www.ncbi.nlm.nih.gov/pubmed/35038827
http://dx.doi.org/10.4143/crt.2021.1133

Ejemplares similares